Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 July 2023 | Story NONSINDISO QWABE | Photo Supplied
Buhle Hlatshwayo
Buhle Hlatshwayo has been selected for the 2023 Fulbright Foreign Language Teaching Assistant (FLTA) Programme.

Buhle Hlatshwayo, a master’s student on the UFS Qwaqwa Campus, has been selected for the 2023 Fulbright Foreign Language Teaching Assistant (FLTA) programme. Despite initially doubting herself, she took a leap of faith and applied for the programme, which turned out to be a successful decision. The Fulbright Programme is a prestigious scholarship programme that provides opportunities for international educational exchanges. The programme’s overarching aim is to enhance intercultural relations across more than 160 countries.

Hlatshwayo will be teaching isiZulu at the University of Georgia in Athens, Georgia, for an academic year. She leaves South Africa at the end of July.

Hlatshwayo is currently pursuing her Master of Arts with specialisation in English on the UFS Qwaqwa Campus, where she also completed her undergraduate and honours degrees in the same field. Her research focuses on East African Arab migration narratives to the Global North, with a focus on exploring the legacies of colonialism. She is also a learning facilitator in the same department.

A prestigious opportunity 

A friend and colleague, Mxolisi Mabaso, encouraged her to apply, knowing her desire to explore opportunities abroad. 

“I am still in awe of how this opportunity came about, especially because someone else saw potential in me while I didn’t believe in myself. My good friend pushed me to apply, because he knew I always wanted the opportunity to go abroad. I am thrilled and honoured to be part of this prestigious programme. I am looking forward to experiencing the US culture and ways of being.”

On her love for English, Hlatshwayo said she has always been fond of the subject but never considered it as a potential career path. After completing her undergraduate degree, Dr Kudzayi Ngara, a Senior Lecturer in the Department of English on the Qwaqwa Campus, encouraged her to pursue an honour’s degree in English, which ultimately shaped her academic journey.

Professional and personal growth awaits

While in the US, Hlatshwayo said she is looking forward to immersing herself in American culture and pursuing courses in American studies. She aims to learn more about diverse cultural backgrounds and share her South African heritage and cultural values with the international community. She said this exchange of experiences and ideas will broaden her horizons and contribute to her academic and professional development.

“The opportunities would not present themselves if you were not capable. If you know your goals, seize any opportunity that will enable you to get there. I was not granted this opportunity because I’m smarter than everyone else, but because of how I articulated my genuine motivations with future goals and how the Fulbright programme will help me achieve them,” she said.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept